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marked with an arrow hanging from the liver. (ColorA 70-YEAR-OLD MAN with no personal history of
interest was diagnosed with cecal carcinoma dur-
ing a colorectal cancer screening. A computed
tomography (CT) body scan for study was
performed prior to the operation. In addition to
the cecal carcinoma, the CT scan showed an
83 3 80 3 50 mm lobed mass of soft tissue in
the right lower quadrant of the abdomen with
well-defined edges and a central, low-density
region, displaying an enhanced periphery and
small punctate calcifications.
This tumor was in continuity with a thick, 6.5-
cm length stalk coming from the lower edge of
the left hepatic lobe (Fig 1). The patient under-
went a laparoscopic operation in which we per-
formed a formal right colectomy and removed a
pendulous tumor hanging from the liver
segment III (Fig 2). The final pathology of the
specimen reported a cecal adenocarcinoma and
a hepatic hemangioma with extensive myxoid
change.
Hepatic hemangioma is the most common
benign tumor of the liver.1 Its prevalence in
autopsy studies ranges between 3–20%.2 Because
patients with hepatic hemangioma often do not
have clear symptoms and most exhibit normal liver
function, tumor progression is monitored without
treatment in many cases.3 The clinical manage-
ment of larger hepatic hemangiomas remains
controversial.1
The main indications for treatment are the
presence of significant clinical symptoms,2,3
suspicion of malignancy, or fear of malignant
transformation.2 Giant hemangiomas have aversion of this figure is available online.)
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x.doi.org/10.1016/j.surg.2016.02.036low but relevant risk of rupture (3.2%),
particularly when peripherally located and exo-
phytic.4 An operation may be considered in
these cases.4 Treatment options should be re-
viewed, and individual patient factors taken
into account.1SURGERY 1
Fig 2. Laparoscopic view of the specimen. (Color
version of this figure is available online.)
ARTICLE IN PRESS
Surgery
j 2016
2 Iba~nez et alSUPPLEMENTARY DATA
Supplementary data related to this article can be found
online at http://dx.doi.org/10.1016/j.surg.2016.02.036.REFERENCES
1. Zhao W, Guo X, Dong J. Spontaneous rupture of hepatic
hemangioma: a case report and literature review. Int J Clin
Exp Pathol 2015;8:13426-8.
2. Choi BY, Nguyen MH. The diagnosis and management of
benign hepatic tumors. J Clin Gastroenterol 2005;39:401-12.
3. Kim JM, Chung WJ, Jang BK, Hwang JS, Kim YH, Kwon JH,
et al. Hemorrhagic hemangioma in the liver: a case report.
World J Gastroenterol 2015;21:7326-30.
4. Mocchegiani F, Vincenzi P, Coletta M, Agostini A, Marzioni M,
Baroni GS, et al. Prevalence and clinical outcome of hepatic
hemangioma with specific reference to the risk of rupture: a
large retrospective cross-sectional study. Dig Liver Dis 2016;
48:309-14.
